Implications of the Novel Mutations in the SARS-CoV-2 Genome for Transmission, Disease Severity, and the Vaccine Development
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative virus of the coronavirus disease 2019 (COVID-19), has been identified in China in late December 2019. SARS-CoV-2 is an enveloped, positive-sense, single-stranded RNA betacoronavirus of the Coronaviridae family. Coronaviruses...
Main Author: | Hikmet Akkiz |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-05-01
|
Series: | Frontiers in Medicine |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmed.2021.636532/full |
Similar Items
-
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
by: Josephine Wambani, et al.
Published: (2022-03-01) -
The Biological Functions and Clinical Significance of SARS-CoV-2 Variants of Corcern
by: Hikmet Akkız
Published: (2022-05-01) -
Emerging SARS-CoV-2 Variants: A Review of Its Mutations, Its Implications and Vaccine Efficacy
by: Sindhu Ramesh, et al.
Published: (2021-10-01) -
Mutations in SARS-CoV-2: Insights on structure, variants, vaccines, and biomedical interventions
by: Ahmed I. Abulsoud, et al.
Published: (2023-01-01) -
The Impact of Evolving SARS-CoV-2 Mutations and Variants on COVID-19 Vaccines
by: Gary McLean, et al.
Published: (2022-04-01)